| Unbound MEDLINE results for: | Bookmark this site | | Articles related to 18194308 [Unique ID], provided by the PubMed system | |
| |
|
| | 1 - 10 of 595 journal articles in the PubMed database | Email to a friend | | |
| Rubinger M, Lillicrap D, Rivard GE, et al.
A prospective surveillance study of factor VIII inhibitor development in the Canadian haemophilia A population following the switch to a recombinant factor VIII product formulated with sucrose. [JOURNAL ARTICLE]
Haemophilia 2008 Jan 8.
Abstract | Full Citation | Find Related Articles | | Delumeau JC, Ikegawa C, Yokoyama C, et al.
An observational study of sucrose-formulated recombinant factor VIII for Japanese patients with haemophilia A. [Journal Article]
Thromb Haemost 2008 Jul; 100(1):32-7.
Abstract | Full Citation | | Yoshioka A, Fukutake K, Takamatsu J, et al.
Clinical Evaluation of Recombinant Factor VIII Preparation (Kogenate) in Previously Treated Patients with Hemophilia A: Descriptive Meta-Analysis of Post-Marketing Study Data. [Journal Article]
Int J Hematol 2006 Aug; 84(2):158-65.
Abstract | Full Citation | Find Related Articles | | Giles AR, Rivard GE, Teitel J, et al.
Surveillance for factor VIII inhibitor development in the Canadian Hemophilia A population following the widespread introduction of recombinant factor VIII replacement therapy. [Journal Article]
Transfus Sci 1998 Jun; 19(2):139-48.
Abstract | Full Citation | Publisher Full Text | Find Related Articles | | Musso R, Santagostino E, Faradji A, et al.
Safety and efficacy of sucrose-formulated full-length recombinant factor VIII: Experience in the standard clinical setting. [JOURNAL ARTICLE]
Thromb Haemost 2008; 99(1):52-58.
Abstract | Full Citation | Find Related Articles | | Yoshioka A, Fukutake K, Takamatsu J, et al.
Clinical evaluation of a recombinant factor VIII preparation (Kogenate) in previously untreated patients with hemophilia A. [Clinical Trial, Clinical Trial, Phase IV, Journal Article]
Int J Hematol 2003 Dec; 78(5):467-74.
Abstract | Full Citation | Find Related Articles | | Rothschild C, Scharrer I, Brackmann HH, et al.
European data of a clinical trial with a sucrose formulated recombinant factor VIII in previously treated haemophilia A patients. [Clinical Trial, Journal Article, Multicenter Study]
Haemophilia 2002 Mar.:10-4.
Abstract | Full Citation | Find Related Articles | | Abshire TC, Brackmann HH, Scharrer I, et al.
Sucrose formulated recombinant human antihemophilic factor VIII is safe and efficacious for treatment of hemophilia A in home therapy--International Kogenate-FS Study Group. [Clinical Trial, Journal Article, Randomized Controlled Trial]
Thromb Haemost 2000 Jun; 83(6):811-6.
Abstract | Full Citation | Publisher Full Text | Find Related Articles | | Giles AR, Verbruggen B, Rivard GE, et al.
A detailed comparison of the performance of the standard versus the Nijmegen modification of the Bethesda assay in detecting factor VIII:C inhibitors in the haemophilia A population of Canada. Association of Hemophilia Centre Directors of Canada. Factor VIII/IX Subcommittee of Scientific and Standardization Committee of International Society on Thrombosis and Haemostasis. [Journal Article, Multicenter Study]
Thromb Haemost 1998 Apr; 79(4):872-5.
Abstract | Full Citation | Find Related Articles |   |
|
| |
Advertise on this site.
|
